Literature DB >> 29671642

Diagnoses of autism spectrum disorders in Germany: Time trends in administrative prevalence and diagnostic stability.

Christian J Bachmann1, Bettina Gerste2, Falk Hoffmann3.   

Abstract

For Germany, no data on trends in autism spectrum disorder diagnoses are available. The primary aim of this study was to establish the time trends in the administrative prevalence of autism spectrum disorder diagnoses. The second aim was to assess the stability of autism spectrum disorder diagnoses over time. We analysed administrative outpatient data (2006-2012) from a nationwide health insurance fund and calculated the prevalence of autism spectrum disorder diagnoses for each year, stratified by age and sex. Additionally, we studied a cohort with a first-time diagnosis of autism spectrum disorder in 2007 through 2012, investigating the percentage of retained autism spectrum disorder diagnoses. From 2006 to 2012, the prevalence of autism spectrum disorder diagnoses in 0- to 24-year-olds increased from 0.22% to 0.38%. In insurees with a first-time autism spectrum disorder diagnosis in 2007, this diagnosis was carried on in all years through 2012 in 33.0% (The International Classification of Diseases, Tenth Revision diagnoses: F84.0/F84.1/F84.5) and 11.2% (F84.8/F84.9), respectively. In Germany, like in other countries, there has been an increase in the administrative prevalence of autism spectrum disorder diagnoses. Yet, prevalences are still lower than in some other Western countries. The marked percentage of autism spectrum disorder diagnoses which were not retained could indicate a significant portion of autism spectrum disorder misdiagnoses, which might contribute to rising autism spectrum disorder prevalences.

Entities:  

Keywords:  Germany; autism spectrum disorders; diagnosis; health services; prevalence; secular trends

Mesh:

Year:  2016        PMID: 29671642     DOI: 10.1177/1362361316673977

Source DB:  PubMed          Journal:  Autism        ISSN: 1362-3613


  25 in total

Review 1.  Epidemiological surveys of ASD: advances and remaining challenges.

Authors:  Eric Fombonne; Heather MacFarlane; Alexandra C Salem
Journal:  J Autism Dev Disord       Date:  2021-04-17

2.  Improving child and adolescent mental health care provision by scrutiny of national diagnostic practices: A call for increased international knowledge exchange.

Authors:  B T H de Veen; J Hebebrand; W G Staal
Journal:  Eur Child Adolesc Psychiatry       Date:  2018-11       Impact factor: 4.785

3.  Diagnostic accuracy of the ADOS and ADOS-2 in clinical practice.

Authors:  I Kamp-Becker; K Albertowski; J Becker; M Ghahreman; A Langmann; T Mingebach; L Poustka; L Weber; H Schmidt; J Smidt; T Stehr; V Roessner; K Kucharczyk; N Wolff; S Stroth
Journal:  Eur Child Adolesc Psychiatry       Date:  2018-03-20       Impact factor: 4.785

4.  Autism spectrum disorder in children with Type 1 diabetes.

Authors:  K E Bethin; L G Kanapka; L M Laffel; S Majidi; N S Chaytor; S MacLeish; R Adams; N C Foster
Journal:  Diabet Med       Date:  2019-07-25       Impact factor: 4.359

5.  A Phase III Study of Bumetanide Oral Liquid Formulation for the Treatment of Children and Adolescents Aged Between 7 and 17 Years with Autism Spectrum Disorder (SIGN 1 Trial): Participant Baseline Characteristics.

Authors:  Christina Georgoula; Maite Ferrin; Bozena Pietraszczyk-Kedziora; Amaia Hervas; Stéphane Marret; Guiomar Oliveira; Antoine Rosier; Véronique Crutel; Emmanuelle Besse; Cristina Albarrán Severo; Denis Ravel; Joaquin Fuentes
Journal:  Child Psychiatry Hum Dev       Date:  2022-03-16

6.  Prevalence of Autism Spectrum Disorder in Children in Andalusia (Spain).

Authors:  Francisco Villegas-Lirola
Journal:  J Autism Dev Disord       Date:  2022-09-08

7.  Prevalence and Characteristics of Autism Spectrum Disorder Among Spanish School-Age Children.

Authors:  Paula Morales-Hidalgo; Joana Roigé-Castellví; Carmen Hernández-Martínez; Núria Voltas; Josefa Canals
Journal:  J Autism Dev Disord       Date:  2018-09

8.  Study protocol of the ASD-Net, the German research consortium for the study of Autism Spectrum Disorder across the lifespan: from a better etiological understanding, through valid diagnosis, to more effective health care.

Authors:  Inge Kamp-Becker; Luise Poustka; Christian Bachmann; Stefan Ehrlich; Falk Hoffmann; Philipp Kanske; Peter Kirsch; Sören Krach; Frieder Michel Paulus; Marcella Rietschel; Stefan Roepke; Veit Roessner; Tanja Schad-Hansjosten; Tania Singer; Sanna Stroth; Stephanie Witt; Anne-Kathrin Wermter
Journal:  BMC Psychiatry       Date:  2017-06-02       Impact factor: 3.630

9.  Pathways to a diagnosis of autism spectrum disorder in Germany: a survey of parents.

Authors:  Juliana Höfer; Falk Hoffmann; Inge Kamp-Becker; Luise Poustka; Veit Roessner; Sanna Stroth; Nicole Wolff; Christian J Bachmann
Journal:  Child Adolesc Psychiatry Ment Health       Date:  2019-03-21       Impact factor: 3.033

10.  Complementary and alternative medicine use in adults with autism spectrum disorder in Germany: results from a multi-center survey.

Authors:  Juliana Höfer; Falk Hoffmann; Inge Kamp-Becker; Charlotte Küpper; Luise Poustka; Stefan Roepke; Veit Roessner; Sanna Stroth; Nicole Wolff; Christian J Bachmann
Journal:  BMC Psychiatry       Date:  2019-02-01       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.